Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Relaxin family peptide receptor 1 (RXFP1), also known as LGR7, is a member of the G protein-coupled receptor (GPCR) superfamily. It is primarily recognized as the cognate receptor for relaxin-2, a hormone with key roles in reproduction and tissue remodeling. RXFP1 contains a large extracellular domain with leucine-rich repeats (LRRs) and an LDLa module. It couples mainly to Gs proteins to stimulate adenylyl cyclase activity, increasing cAMP levels, but can also couple to GoB or Gi proteins. RXFP1 plays critical roles in female reproduction, male fertility, and cardiovascular system modulation.
Gs/Gi protein coupling leading to cAMP modulation, PKCζ pathway activation, and MAPK pathway activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Relaxin Family Peptide Receptor 1 (RXFP1).